Recombinant Mouse Siglec-3/CD33 Fc Chimera Protein, CF

R&D Systems, part of Bio-Techne | Catalog # 10102-SL

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
10102-SL-050
100% Guarantee

Key Product Details

Source

NS0

Accession #

Q63994

Structure / Form

Disulfide-linked homodimer

Conjugate

Unconjugated

Applications

Bioactivity

View all Siglec-3/CD33 Proteins and Enzymes »

Product Specifications

N-terminal Sequence Analysis

Gln17 inferred from enymatic pyroglutamate treatment revealing Asp18

Predicted Molecular Mass

52 kDa

SDS-PAGE

55-75 kDa, under reducing conditions

Scientific Data Images for Recombinant Mouse Siglec-3/CD33 Fc Chimera Protein, CF

Recombinant Mouse Siglec-3/CD33 Fc Chimera Protein SDS-PAGE

Recombinant Mouse Siglec-3/CD33 Fc Chimera Protein SDS-PAGE

2 μg/lane of Recombinant Mouse Siglec-3/CD33 Fc Chimera (Catalog # 10102-SL) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 55-75 kDa and 110-150 kDa, respectively.

Formulation, Preparation and Storage

10102-SL
Formulation Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Reconstitution Reconstitute at 500 μg/mL in PBS.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Store the unopened product at -20 to -70 °C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.

Background: Siglec-3/CD33

Siglec-3 (sialic acid binding Ig-like lectin 3), also known as myeloid cell surface antigen CD33 and GP67, is an I-type (Ig-type) lectin belonging to the Ig superfamily. Siglecs are characterized by an N-terminal Ig-like V-type domain, which mediates sialic acid binding, followed by varying numbers of Ig-like C2-type domains (1, 2). Fourteen human and nine mouse Siglecs have been characterized and are divided into 2 families: CD33 related and evolutionarily conserved (3). Mature mouse Siglec-3 consists of a 224 amino acid (aa) extracellular domain (ECD), containing one IgV and one IgC2 domain and shares 56% aa identity with human Siglec-3. Mouse Siglec-3 is expressed on myeloid precursors in the bone marrow, mostly in the mature stages of the granulocytic lineage (4). Each Siglec has a distinct preference for binding the various types of sialylated glycans found on the surface of mammalian cells and they most likely evolved to regulate host immune responses via the recognition of self-glycans (5). Unlike human Siglec-3, mouse Siglec-3 lacks a canonical cytoplasmic ITIM domain. Instead, mouse Siglec-3 possesses a charged amino acid in its transmembrane domain, which may interact with an ITAM adaptor protein (6). Additionally, mouse Siglec-3 binds sialic acids found on mucins rather than alpha2-3- or alpha2-6-linked sialic acids on lactosamine units to which human Siglec-3 binds (7, 8). These differences suggest mouse and human Siglec-3 might not be functionally identical (8). Human Siglec-3 continues to be a therapeutic target for the treatment of acute myeloid leukemia and is a high potential risk factor for Alzheimer's (9).

Long Name

Sialic Acid Binding Ig-like Lectin 3

Alternate Names

CD33, gp67, Siglec3

Entrez Gene IDs

945 (Human); 12489 (Mouse); 102117580 (Cynomolgus Monkey)

Gene Symbol

CD33

UniProt

Q63994 (Mouse)

Additional Siglec-3/CD33 Products

Product Documents for Recombinant Mouse Siglec-3/CD33 Fc Chimera Protein, CF

Product Datasheets

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Download SDS

Manufacturing Specifications

  1. Crocker, P.R. and Varki, A. (2001) Trends Immunol. 22:337.
  2. Crocker, P.R. and Varki, A. (2001) Immunology 103:137.
  3. Macauley, M.S. et al. (2014) Nat. Rev. Immunol. 14:653.
  4. Varki, A. et al. (2017) Essentials of Glycobiology. Chapter 35.
  5. Paulson, J. et al. (2012) Ann. N. Y. Acad. Sci. 1253:37.
  6. Pillai, S. et al. (2012) Ann. Rev. Immunol. 30:357.
  7. Brinkman-Van der Linden, E.C. and Varki, A. (2000) J. Bio. Chem. 275:8633.
  8. Brinkman-Van der Linden, E.C. et al. (2003) Mol. Cell. Bio. 23:4199.
  9. Malik, M. et al. (2013) J. Neurosci. 33:13320.

Product Specific Notices for Recombinant Mouse Siglec-3/CD33 Fc Chimera Protein, CF

For research use only

Privacy and Cookie Policy
Site Map
© Copyright 2024 Bio-Techne. All Rights Reserved.